Karen Smith - Concepedia

Author

Karen Smith

University of Glasgow ORCID

Also Known As

D. Smith, K M Smith, K Smith, K. M. Smith, K. SMITH, K. Smith, K.M. Smith, K. M. SMITH, KAREN M. SMITH, Karen M Smith

156

Publications

10.5K

Citations

H-Index

148

Concepts

All Affiliations

University of Glasgow Boston University Geriatric Research Education and Clinical Center Harvard University Yale University

About

Karen Smith is an author at University of Glasgow specializing in medicine, cell biology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	43	4.2K
2	Health Sciences	5	5	464
3	Natural Sciences	3	3	97
4	Engineering	2	2	40
5	Public Health	1	1	55

Karen Smith

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice Robert J. Ferrante, James K. Kubilus, Junghee Lee, Journal of Neuroscience	2003	687
Sodium phenylbutyrate prolongs survival and regulates expression of anti‐apoptotic genes in transgenic amyotrophic lateral sclerosis mice Hoon Ryu, Karen Smith, Sandra Camelo, Journal of Neurochemistry	2005	350
Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease Jae-Hwan Kim, Jennifer P. Moody, Christina K. Edgerly, Human Molecular Genetics Neurodegenerative DiseasesMitochondrial LossMitochondrial FunctionMitochondrial DysfunctionMitochondrial Biogenesis	2010	339
ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease Hoon Ryu, Junghee Lee, Sean W. Hagerty, Proceedings of the National Academy of Sciences	2006	320
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis Sandra Camelo, Antonio Iglesias, Daehee Hwang, Journal of Neuroimmunology Autoimmune DiseaseHistone Deacetylase InhibitorAutoantibody ProductionTranscriptional TherapyAutophagy	2005	270
Efficacy of common hospital biocides with biofilms of multi-drug resistant clinical isolates Karen Smith, Iain S. Hunter Journal of Medical Microbiology BiofilmsPathogenic MicrobiologyNosocomial PathogensMrsa BiofilmsHealth Sciences	2008	264
Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice Edward C. Stack, James K. Kubilus, Karen Smith, The Journal of Comparative Neurology	2005	246
Combination therapy with Coenzyme Q<sub>10</sub> and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases Lichuan Yang, Noel Y. Calingasan, Elizabeth Wille, Journal of Neurochemistry Synaptic SignalingSocial Sciences3-Np Rat ModelOxidative StressNeurobiology Of Disease	2009	230
T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus. Christine Jolicoeur, Douglas Hanahan, Karen Smith Proceedings of the National Academy of Sciences Tag MrnaLymphocyte DevelopmentT-regulatory CellImmunologyT Antigen	1994	222
Chemotherapy for the Brain: The Antitumor Antibiotic Mithramycin Prolongs Survival in a Mouse Model of Huntington's Disease Robert J. Ferrante, Hoon Ryu, James K. Kubilus, Journal of Neuroscience Molecular BiologyCell DeathMithramycin TreatmentAntimicrobial ChemotherapyEpigenetics	2004	195

Page 1